At a glance
ClinicalIndex Comparison RecordN/ACompleted· 41 enrolled
Drug / intervention
High flow nasal cannula +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized. Controlled Trial of the Utilization of High Flow Nasal Cannula for Oxygenation of Sedated Morbidly Obese Patients in the Endoscopy Suite
In Brief
A clinical study evaluating High flow nasal cannula and Nasal Cannula for Morbid Obesity and 2 related conditions. Completed, enrolled 41 participants across 1 site.
Detailed Summary
This study evaluates the ability of high flow nasal cannula versus nasal cannula to oxygenate morbidly obese patients undergoing moderate to deep sedation for gastrointestinal procedures.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMorbid Obesity, Noninvasive Ventilation, Deep Sedation
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 2016
Enrollment StartDec 2016
Primary CompletionSep 2018
TodayJul 2026
First PostedAug 9, 2016
Enrollment StartDec 28, 2016
Primary CompletionSep 28, 2018
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 9.9 years ago
Interventions
High flow nasal cannuladevice
High flow nasal cannula at 50 liters per minute and 50% oxygen will initially be used for oxygenation.
Nasal Cannuladevice
Control group will receive oxygen via standard flow nasal cannula at 5 liters per minute (approximately an FiO2 of 0.35)